Sat.Oct 02, 2021 - Fri.Oct 08, 2021

Relay's targeted cancer drug could be safer than its competitors. Is it more effective?

Bio Pharma Dive

Initial study results for Relay's experimental treatment offer some support for the biotech's protein motion technology, but raise some questions, too

Pharma is “big business” that uses excuses to keep prices high

World of DTC Marketing

SUMMARY: Americans spend twice as much per capita on drugs as residents of other wealthy nations, because ours is the only country that lets drugmakers set any price they want for their products.

Sales 224
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Open Source “Wikipedia” for Drug Discovery

Pharma Mirror

By Kambiz Shekdar, Ph.D. Open source drug discovery was proposed in the past in connection with third-world diseases like tuberculosis and malaria, but it is in the context of first-world indications where it is needed most.

A novel neural network to understand symmetry, speed materials research

Scienmag

Understanding structure-property relations is a key goal of materials research, according to Joshua Agar, a faculty member in Lehigh University’s Department of Materials Science and Engineering.

Gene therapy developer gets chance at a comeback with Pfizer deal

Bio Pharma Dive

Voyager Therapeutics recently scrapped much of its pipeline and replaced top executives. Now, a Pfizer deal on new technology gives investors hope

The social media problem for healthcare

World of DTC Marketing

SUMMARY: The Facebook whistleblower lawsuit can be summed up in one sentence: Facebook prioritizes engagement above all else because it leads to more profits even if that engagement containing inflammatory information.

CPhI Worldwide: 9-11 November 2021 in Milan, Italy

Pharma Mirror

“In a year when literally hundreds of our exhibitors have contributed to overcoming COVID, the greatest healthcare challenge of recent times, we are delighted to be welcoming back the pharma community.

More Trending

Intergalactic Therapeutics launches with $75M to build a new type of gene therapy

Bio Pharma Dive

Founded by former Biogen executive Michael Ehlers and backed by Apple Tree Partners, Intergalactic aims to create non-viral gene therapies delivered via an advanced form of electroporation

Moderna executives join Forbes richest at taxpayers expense

World of DTC Marketing

SUMMARY: (Times) The financial windfall at Moderna, the biotech company behind one of the three federally cleared Covid-19 vaccines, has propelled three new names onto Forbes magazine’s list of the 400 wealthiest people in the United States. However, it’s the NIH’s vaccine.

Three Ways Pharma Advertisers Can Benefit from Attention Metrics

Pharma Marketing Network

By: Marc Guldimann, Co-founder and CEO, Adelaide. Targeting and attribution challenges are universal, but pharmaceutical advertisers encounter several unique hurdles with digital advertising.

A cousin of Viagra reduces obesity by stimulating cells to burn fat, study shows

Scienmag

Drugs 83

Allogene cell therapy trials halted by FDA after safety finding

Bio Pharma Dive

Researchers found evidence of a "chromosomal abnormality" in one patient treated with Allogene's CAR-T cell therapy, spurring the clinical hold and an investigation

Trials 241

Merck gives taxpayers the middle finger

World of DTC Marketing

SUMMARY: Via Axios – The antiviral pill that showed promising results against severe COVID-19 was initially developed at Emory University with $35 million of taxpayer grants. And while it costs $17.74

Collins Calls Time for a Change, Steps Down as NIH Director

BioSpace

After serving three presidential administrations, Dr. Francis S. Collins is stepping down as director of the National Institutes of Health at the end of the year

107
107

Parent Project Muscular Dystrophy’s ground-breaking effort

Scienmag

Sarepta embarks on late-stage clinical trial of Duchenne gene therapy

Bio Pharma Dive

Initiation of the Phase 3 trial is an important milestone for the biotech after earlier setbacks, as well as for patients with the inherited muscle disease

Just how bad is Facebook health information? Really bad

World of DTC Marketing

SUMMARY: The health information on Facebook is a danger to anyone who reads it. Experiences from current patients do provide some context but too often contain lousy advice.

Rejuvenate Bio is Reversing Age-Related Diseases to Increase Healthspan

BioSpace

Unlike most companies addressing the diseases associated with aging, Rejuvenate Bio tackles multiple cardiac, metabolic and renal issues at once

101
101

Oregon State microbiology research furthers understanding of ocean’s role in carbon cycling

Scienmag

CORVALLIS, Ore. Microbiology researchers at Oregon State University have shed new light on the mechanisms of carbon cycling in the ocean, using a novel approach to track which microbes are consuming different types of organic carbon produced by common phytoplankton species.

Armed with half a billion dollars, a startup aims to change how brain drugs are made

Bio Pharma Dive

Neumora Therapeutics launched Thursday with a $100 million investment from Amgen and another $400 million from a long list of venture capital firms, including Arch, which is taking another shot at building a neuroscience company

Drugs 227

The ‘patient of the future’ is driving radical innovation in healthcare

Pharma Phorum

Digital data collection, utilisation of real-word data and patient-centric thinking will all contribute to the rapid development of a new healthcare landscape, says Debiopharm Innovation Fund’s Tanja Dowe.

First subject given COVID-19 vaccine candidate in UK-based Scancell’s COVIDITY trial

Pharma Times

UK-based Scancell Holdings has announced that its first subject has been dosed in its COVIDITY clinical trial in South Africa

Elastic polymer that is both stiff and tough, resolves long-standing quandary

Scienmag

Polymer science has made possible rubber tires, Teflon and Kevlar, plastic water bottles, nylon jackets among many other ubiquitous features of daily life.

Takeda halts studies of touted sleep disorder drug over safety concern

Bio Pharma Dive

The drugmaker suspended dosing in two mid-stage studies of its experimental narcolepsy treatment after a "safety signal" emerged

Drugs 227

Twin Health raises $140m for “digital twin” diabetes reversal app

Pharma Phorum

The developer of a toolkit that promises to create a “digital twin” of individuals with chronic metabolic diseases like diabetes to help model the impact of lifestyle changes has secured $140 million in funding to develop the technology.

First Long-Acting Antibody Cocktail to Prevent COVID-19 Submitted for EUA

BioSpace

AstraZeneca submitted data for an Emergency Use Authorization for AZD7442, a long-acting antibody combination from B-cells donated by patients who recovered from COVID-19

Deep-learning algorithm aims to accelerate protein engineering

Scienmag

Machine learning algorithms assist in protein engineering by reducing the experimental burden of methods such as directed evolution, which involves multiple rounds of mutagenesis and high-throughput screening.

Collins to step down as NIH head in transition for research agency

Bio Pharma Dive

After 12 years in the top job, the veteran director says a new scientist should assume leadership of the world's largest biomedical research institution

Medtronic Expands Two Insulin Pump Recalls, Including One Over Cybersecurity Concerns

XTalks

Medtronic has expanded a Class I recall of remote controllers used with the MiniMed 508 insulin pump or the MiniMed Paradigm family of insulin pumps over potential cybersecurity risks. The affected remote controller models are MMT-500 and MMT-503.

3D-Printed Vaccine Patch Offers Enhanced Immune Response, Comfort Level

BioSpace

The patch is not only painless, it requires less vaccine to generate the same or greater effects

How mussels make a powerful underwater glue

Scienmag

Blue mussels (Mytilus edulis) spend their days being buffeted by crashing waves. They manage to stay tethered to the rocks or their fellow mussels thanks to a highly effective underwater glue they produce.

J&J heats up RSV race with new vaccine data

Bio Pharma Dive

The company's candidate is one of two to enter late-stage testing for a respiratory virus that causes hundreds of thousands of hospitalizations a year

Fungus-derived cancer killing drug by Oxford University shows promise

Pharma Times

A chemotherapy drug, NUC-7738, which is derived from a Himalayan fungus has been found to have 40 times greater potency in killing cancer cells than its original parent compound

Drugs 88

Transform patient experience with intelligent hyper-personalisation

Pharma Phorum

Since 2019, pharmaceutical companies have been speeding to integrate digital channels and processes into their marketing efforts and patient outreach, to prepare for the wave of digitisation in the healthcare industry.

Hopkins Med newsletter 7

Scienmag

How a busy year for biotech IPOs measures up at the three-quarter mark

Bio Pharma Dive

Drugmaker initial public offerings could break records set just a year ago. But valuations and stock performance have slipped from historic highs

220
220

Stakeholder Collaborations Essential to Making Things Happen in Rare Disease Space

BioSpace

Patients and patient organizations, which have detailed insights in the natural history of a rare disease, should be integral, too

87